본문바로가기

HOME

PRODUCT

EUSRA™

EUSRA™ EUS-guided RFA treatment

Video clip

Indication

● Pancreatic tumor (locally advanced pancreatic cancer, pancreatic neuroendocrine tumor, pancreatic cysts, etc)
● Extra pancreatic tumor (liver, adrenal, kidney, GI gyst, etc)


Features

● Feasible and safe ablative treatment for locally advanced unresectable pancreatic cancer, neuroendocrine tumors, and cystic neoplasms
● An easy approach to the target lesion with a great pushability of the needle
● Good echogenicity for safe procedure under EUS-guidance
● Inner cooling system making it possible to ablate large volumes of tumor without tissue charring

● The electrode is a monopolar system and needs ground pads
● Optimal RFA needle operating with VIVA Combo™ generators only




Ordering Information

EUS Approach

 Code

Tip Length (mm) 

Flexible Length (mm)

Tip Diameter 

 19-**E

5, 7, 10, 15, 20, 25, 30

1393 ± 20 (7Fr)

19G (1.06mm) 




Articles

EUS-guided radiofrequency ablation of the porcine pancreas

Gastrointestinal Endoscopy Vol.76, No.5: 2012 Dong-Wan Seo, MD, PhD


 Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer
Gastrointestinal endsocopy 2015 Dong Wan Seo, MD, PhD


 EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos)
Gastrointestinal Endsocopy 2015 Sundeep Lakhtakia, MD, DM, MNAMS, FASGE


 Endoscopic ultrasound-guided radiofrequency ablation of a pancreatic neuroendocrine tumor
Endsoscopy 2015 Elia Armellini, Stefano F. Crino, Marco Ballare, Pietro Occhipinti, MD, Italy


 Electrode radiofrequency ablation EUS-guided-EUSRA
Giornale Italiano Di Endoscopia Digestiva, Marzo 2017 Elia Armellini et al.


 Cushing's syndrome managed by endoscopic ultrasound-guided radiofrequency ablation of adrenal gland adenoma
Endoscopy 2017;49:E1-E2 Dong Wan Seo, MD, PhD

Welcome to Taewoong Medical International.
Sign up with your email to receive the Latest News Feeds.
We respect your privacy.

An error ocurred, please check your input.

THANK YOU FOR YOUR INTEREST! You have been added to our Subscriber List.

We respect your privacy.